RSLS stock forecast
Our latest prediction for ReShape Lifesciences, Inc.'s stock price was made on the Jan. 29, 2020 when the stock price was at 8.00$.
In the short term (2weeks), RSLS's stock price should underperform the market by -1.62%. During that period the price should oscillate between -14.60% and +17.88%.
In the medium term (3months), RSLS's stock price should underperform the market by -9.73%. During that period the price should oscillate between -50.09% and +38.63%.Get email alerts
Create a solid portfolio with RSLS
About ReShape Lifesciences, Inc.
ReShape Lifesciences Inc. operates as a medical device company, which focuses on technology to treat obesity and metabolic diseases. It operates through the following segments: Lap-Band, ReShape Vest and ReShape vBloc. The company was founded in December 2002 and is headquartered in San Clemente, CA.
At the moment the company generates 11M USD in revenues.
On its last earning announcement, the company reported a profit of 2231.11$ per share.
The book value per share is 0.64$
Three months stock forecastJan. 29, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|